Read More Analyst Ratings News Price Target Truist Securities Maintains Buy on Enphase Energy, Raises Price Target to $290 By Benzinga Newsdesk Today, 9:21 PM Truist Securities analyst Bronson Fleig maintains Enphase Energy (NASDAQ:ENPH) with a Buy and raises the price target from $265 to $290. ENPH
Read More News Microsoft To Integrate ‘Teams’ Messaging Software Directly Into Windows Operating System By Michael Horton Today, 9:21 PM -Reuters MSFT
Read More Earnings Looking Into Amarin Corp’s Return On Capital Employed By Benzinga Insights Today, 9:21 PM According to Benzinga Pro, during Q4, Amarin Corp (NASDAQ:AMRN) earned $14.70 million, a 211.76% increase from the preceding quarter. Amarin Corp also posted a total of $144.49 million in sales, a 1.73% increase since Q3. AMRN
Read More General Health Care News Top Stories J&J Settles Anti-psychotic Drug Risperdal Lawsuits With $800 Million In Expenses By Bibhu Pattnaik Today, 9:21 PM Johnson & Johnson (NYSE: JNJ) says it has settled most of the lawsuits in the anti-psychotic drug Risperdal cases and has recorded $800 million JNJ